Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138133723> ?p ?o ?g. }
- W2138133723 abstract "In Canada, two vaccines that have demonstrated high efficacy against infection with human papillomavirus (HPV) types -16 and -18 are available. The HPV-6/11/16/18 vaccine provides protection against genital warts (GW) while the HPV-16/18 vaccine may provide better protection against other oncogenic HPV types. In this analysis, the estimated clinical and economic benefit of each of these vaccines was compared in the Canadian setting.A Markov model of the natural history of HPV infection among women, cervical cancer (CC) and GW was used to estimate the impact of vaccinating a cohort of 100,000 12-year-old females on lifetime outcomes and healthcare system costs (no indirect benefit in males included). A budget impact model was used to estimate the impact of each vaccine by province.In the base case, vaccination with the HPV-16/18 vaccine was predicted to prevent 48 additional CC cases, and 16 additional CC deaths, while vaccination with the HPV-6/11/16/18 vaccine was predicted to prevent 6,933 additional GW cases. Vaccination with the HPV-16/18 vaccine was estimated to save 1 additional discounted quality adjusted life year (QALY) at an overall lower lifetime cost to the healthcare system compared to the HPV-6/11/16/18 vaccine (assuming vaccine price parity). In sensitivity analyses, the HPV-6/11/16/18 vaccine was associated with greater QALYs saved when the cross-protection efficacy of the HPV-16/18 vaccine was reduced, or the burden of GW due to HPV-6/11 was increased. In most scenarios with price parity, the lifetime healthcare cost of the strategy with the HPV-16/18 vaccine was predicted to be lower than the HPV-6/11/16/18 vaccine. In the probabilistic sensitivity analyses, the HPV-16/18 vaccine provided more QALY benefit than the HPV-6/11/16/18 vaccine in 49.2% of scenarios, with lower relative lifetime costs in 83.5% of scenarios.Overall, the predicted lifetime healthcare costs and QALYs saved by implementing each of the vaccines are similar. Vaccination with the HPV-16/18 vaccine is expected to be associated with reduced CC disease morbidity and mortality compared to vaccination with the HPV-6/11/16/18 vaccine. Differences in these outcomes depend on the extent of cervical disease prevented by cross-protection and the burden of GW caused by HPV-6/11." @default.
- W2138133723 created "2016-06-24" @default.
- W2138133723 creator A5009015320 @default.
- W2138133723 creator A5047502807 @default.
- W2138133723 creator A5050484693 @default.
- W2138133723 creator A5074085811 @default.
- W2138133723 creator A5085268308 @default.
- W2138133723 date "2012-10-13" @default.
- W2138133723 modified "2023-09-23" @default.
- W2138133723 title "Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada" @default.
- W2138133723 cites W1585890709 @default.
- W2138133723 cites W1906037527 @default.
- W2138133723 cites W1969228545 @default.
- W2138133723 cites W1979240321 @default.
- W2138133723 cites W1987045012 @default.
- W2138133723 cites W1988590161 @default.
- W2138133723 cites W1992519297 @default.
- W2138133723 cites W1996738480 @default.
- W2138133723 cites W1997384168 @default.
- W2138133723 cites W2014332916 @default.
- W2138133723 cites W2018349325 @default.
- W2138133723 cites W2020830322 @default.
- W2138133723 cites W2021427213 @default.
- W2138133723 cites W2023668318 @default.
- W2138133723 cites W2039745983 @default.
- W2138133723 cites W2047391869 @default.
- W2138133723 cites W2053940510 @default.
- W2138133723 cites W2061017376 @default.
- W2138133723 cites W2078615887 @default.
- W2138133723 cites W2080283957 @default.
- W2138133723 cites W2086404290 @default.
- W2138133723 cites W2098491904 @default.
- W2138133723 cites W2101196984 @default.
- W2138133723 cites W2101991638 @default.
- W2138133723 cites W2102855188 @default.
- W2138133723 cites W2109337527 @default.
- W2138133723 cites W2112846077 @default.
- W2138133723 cites W2114391710 @default.
- W2138133723 cites W2123962939 @default.
- W2138133723 cites W2125112713 @default.
- W2138133723 cites W2125223938 @default.
- W2138133723 cites W2126246455 @default.
- W2138133723 cites W2127043059 @default.
- W2138133723 cites W2127728552 @default.
- W2138133723 cites W2127866283 @default.
- W2138133723 cites W2134537888 @default.
- W2138133723 cites W2135671488 @default.
- W2138133723 cites W2136236728 @default.
- W2138133723 cites W2139349670 @default.
- W2138133723 cites W2141226130 @default.
- W2138133723 cites W2144870957 @default.
- W2138133723 cites W2150436558 @default.
- W2138133723 cites W2150550346 @default.
- W2138133723 cites W2153867119 @default.
- W2138133723 cites W2158756183 @default.
- W2138133723 cites W2159831861 @default.
- W2138133723 cites W2164328573 @default.
- W2138133723 cites W2166678252 @default.
- W2138133723 cites W2166806711 @default.
- W2138133723 cites W4239606454 @default.
- W2138133723 doi "https://doi.org/10.1186/1471-2458-12-872" @default.
- W2138133723 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3503751" @default.
- W2138133723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23061913" @default.
- W2138133723 hasPublicationYear "2012" @default.
- W2138133723 type Work @default.
- W2138133723 sameAs 2138133723 @default.
- W2138133723 citedByCount "11" @default.
- W2138133723 countsByYear W21381337232013 @default.
- W2138133723 countsByYear W21381337232014 @default.
- W2138133723 countsByYear W21381337232016 @default.
- W2138133723 countsByYear W21381337232017 @default.
- W2138133723 countsByYear W21381337232020 @default.
- W2138133723 crossrefType "journal-article" @default.
- W2138133723 hasAuthorship W2138133723A5009015320 @default.
- W2138133723 hasAuthorship W2138133723A5047502807 @default.
- W2138133723 hasAuthorship W2138133723A5050484693 @default.
- W2138133723 hasAuthorship W2138133723A5074085811 @default.
- W2138133723 hasAuthorship W2138133723A5085268308 @default.
- W2138133723 hasBestOaLocation W21381337231 @default.
- W2138133723 hasConcept C121608353 @default.
- W2138133723 hasConcept C126322002 @default.
- W2138133723 hasConcept C159047783 @default.
- W2138133723 hasConcept C203014093 @default.
- W2138133723 hasConcept C22070199 @default.
- W2138133723 hasConcept C2778220009 @default.
- W2138133723 hasConcept C2778308922 @default.
- W2138133723 hasConcept C2778580637 @default.
- W2138133723 hasConcept C2780441014 @default.
- W2138133723 hasConcept C2994532551 @default.
- W2138133723 hasConcept C71924100 @default.
- W2138133723 hasConcept C72563966 @default.
- W2138133723 hasConceptScore W2138133723C121608353 @default.
- W2138133723 hasConceptScore W2138133723C126322002 @default.
- W2138133723 hasConceptScore W2138133723C159047783 @default.
- W2138133723 hasConceptScore W2138133723C203014093 @default.
- W2138133723 hasConceptScore W2138133723C22070199 @default.
- W2138133723 hasConceptScore W2138133723C2778220009 @default.
- W2138133723 hasConceptScore W2138133723C2778308922 @default.
- W2138133723 hasConceptScore W2138133723C2778580637 @default.
- W2138133723 hasConceptScore W2138133723C2780441014 @default.